InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Ray Russell T. Officer active across 2 companies, notably Merrimack Pharmaceuticals INC. Cumulatively, 7 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €3k. Activity tracked since 31 December 2021. The latest transaction was disclosed on 4 September 2023 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ray Russell T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
21,455 股@ US$1.3634.1% 占其流量Common StockSEC:0001213900-23-075377:0
30,702 股0Common StockSEC:0001213900-22-068720:0
13,068 股0Common StockSEC:0001213900-22-042959:0
10,570 股@ US$1.3617.1% 占其流量Common StockSEC:0001213900-22-042957:0
10,570 股@ US$1.3625.6% 占其流量Common StockSEC:0001213900-22-028982:0
4,728 股@ US$3.0423.6% 占其流量Common StockSEC:0001213900-22-002425:0
1,000 股@ US$3.8398100.0% 占其流量Common StockSEC:0000899243-22-000473:0
7 条申报中的 7 条
About Ray Russell T
Ray Russell T is a declarant linked to 180 Life Sciences Corp. and Merrimack Pharmaceuticals INC, where he is a director. The record shows 7 filings in total. In the sampled recent filings, the period runs from 2022-01-04 to 2023-09-08, with EUR 0 of buys and EUR 3391 of sells, and the stated transaction nature is Attribution.
